Filtered By:
Specialty: Cardiology
Condition: Dementia

This page shows you your search results in order of relevance. This is page number 4.

Order by Relevance | Date

Total 319 results found since Jan 2013.

Post-stroke dementia is associated with increased subsequent all-cause mortality: A population-based cohort study
We aimed to determine whether patients with post-stroke dementia (PSD) have increased mortality risk in Taiwan.
Source: Atherosclerosis - March 12, 2019 Category: Cardiology Authors: Tomor Harnod, Cheng-Li Lin, Chung Y. Hsu, Chia-Hung Kao Source Type: research

Your Eyes May Signal Stroke, Dementia Risk
Title: Your Eyes May Signal Stroke, Dementia RiskCategory: Health NewsCreated: 3/11/2021 12:00:00 AMLast Editorial Review: 3/11/2021 12:00:00 AM
Source: MedicineNet Heart General - March 11, 2021 Category: Cardiology Source Type: news

Impact of Catheter Ablation on Stroke, Cognitive Decline and Dementia
AF is the most common sustained arrhythmia, both clinically and worldwide, with a lifetime incidence estimated at ~20%.1,2 The total number of cases of AF in the US is expected to exceed 2.5 million by the year 2030 and 7.5 million by 2050.3,4 Furthermore, AF carries significant morbidity and is one of the leading causes for hospitalisation in the US, with annual AF admiss...
Source: Radcliffe Cardiology - October 27, 2021 Category: Cardiology Authors: c242508f1d9059bc0f2aa9bdd5421ba2 Source Type: research

Differences in oral anticoagulant prescriptions between specialists and non-specialists in patients with cardioembolic stroke caused by non-valvular atrial fibrillation
In conclusion, the OAC prescription rate was higher in patients with non-valvular AF whose family physicians were specialists at the time of cerebral infarction onset. In addition, in the SG, advanced age and hypertension were associated with not prescribing OAC, whereas a higher CHADS2 score was associated with the prescription of OACs. In the NSG, a history of cerebral infarction was associated with the prescription of OACs. Further, paroxysmal AF, antiplatelet drug use, and dementia were associated with non-OAC therapy in both the groups.
Source: Heart and Vessels - April 7, 2022 Category: Cardiology Source Type: research

Preserve the Brain Primary Goal in the Therapy of Atrial Fibrillation ∗
Treatment of atrial fibrillation (AF) involves 3 major strategies: prevention of stroke, maintenance of sinus rhythm, and rate control (1). Stroke is the most dreaded complication of AF, and its prevention is key. Anticoagulation with warfarin and the newer agents dabigatran, rivaroxaban, and apixaban is highly effective in preventing strokes in patients with AF (1,2,3,4). However, defining the appropriate patient for anticoagulant therapy is not an exact science, and the stroke risk schema CHADS2 (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, previous Stroke/transient ischemic attack) and CH...
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - July 29, 2013 Category: Cardiology Source Type: research

Preserve the Brain: Primary Goal in the Therapy of Atrial Fibrillation∗
Treatment of atrial fibrillation (AF) involves 3 major strategies: prevention of stroke, maintenance of sinus rhythm, and rate control . Stroke is the most dreaded complication of AF, and its prevention is key. Anticoagulation with warfarin and the newer agents dabigatran, rivaroxaban, and apixaban is highly effective in preventing strokes in patients with AF . However, defining the appropriate patient for anticoagulant therapy is not an exact science, and the stroke risk schema CHADS2 (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, previous Stroke/transient ischemic attack) and CHA2DS2-VASc (...
Source: Journal of the American College of Cardiology - May 17, 2013 Category: Cardiology Authors: Eric N. Prystowsky, Benzy J. Padanilam Tags: Heart Rhythm Disorders: Editorial Comment Source Type: research

Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment
Lancet Neurol. 2022 Feb 7:S1474-4422(21)00376-8. doi: 10.1016/S1474-4422(21)00376-8. Online ahead of print.ABSTRACTIntracranial atherosclerotic stenosis (ICAS) is one of the most frequent causes of stroke worldwide and confers one of the greatest risks of recurrent stroke compared with other causes of stroke. Asymptomatic ICAS is increasingly recognised as a risk factor for silent brain infarctions and dementia, magnifying the global burden of ICAS. Although ICAS is a lumen-based diagnosis, newer diagnostic imaging techniques, such as high-resolution MRI, might help to identify high-risk population subgroups to test interv...
Source: Atherosclerosis - February 10, 2022 Category: Cardiology Authors: Jose Gutierrez Tanya N Turan Brian L Hoh Marc I Chimowitz Source Type: research

Coût de la prise en charge des accidents vasculaires cérébraux en France
Conclusion Les AVC génèrent une dépense importante pour la collectivité, qui ne se résume pas à la prise en charge de l'évènement initial et qui va courir jusqu'au décès des patients. La prise en charge médico-sociale du handicap représente en particulier un poste important, qui reste mal connu dans le contexte français. Background In France, stroke is the first cause of acquired disability for adults, the second cause of dementia and the third cause of death. Nonetheless, their economic burden for society is insufficiently documented. Aims The aim of the study was to synthetize existing published data on th...
Source: Archives of Cardiovascular Diseases Supplements - March 15, 2016 Category: Cardiology Source Type: research

Cerebral Embolism A Silent Iatrogenic Complication of TAVR That Needs Voiced  Consideration ∗
Transcatheter aortic valve replacement (TAVR) has rapidly and definitely changed the way patients with aortic stenosis are treated. Both the number of procedures and the indications have increased worldwide, allowing the inoperable patient to be treated, the high risk patient to be treated less invasively, and the intermediate risk patient to have the choice of an alternative to surgery (1–4). Clinical stroke or transient ischemic attack is not uncommon after aortic stenosis treatment, ranging in the randomized studies from 5% to 6% at 30 days to 8% to 10% at 1 year —one-half of them being major/disabling strokes (Tabl...
Source: Journal of the American College of Cardiology - August 2, 2016 Category: Cardiology Source Type: research

Effectiveness and Safety of Rivaroxaban by General Practitioners  - A Multicenter, Prospective Study in Japanese Patients With Non-Valvular Atrial Fibrillation (GENERAL)
CONCLUSIONS: The low incidence of adverse events, including stroke/SE and bleeding, in patients prescribed rivaroxaban by general practitioners supports its use as a safe and efficacious treatment in the standard clinical care of high-risk patient populations.PMID:33814525 | DOI:10.1253/circj.CJ-20-1244
Source: Circulation Journal - April 5, 2021 Category: Cardiology Authors: Kengo Kusano Nobuyoshi Sugishita Masaharu Akao Hikari Tsuji Kunihiko Matsui Shinya Hiramitsu Yutaka Hatori Hironori Odakura Hiroyuki Kamada Koji Miyamoto Hisao Ogawa Source Type: research

Carotid Stiffness: A Novel Cerebrovascular Disease Risk Factor
Carotid stiffening is considered an important element in the pathogenesis of cerebrovascular diseases. These include stroke as well as vascular dementia and depression. However, results of individual studies evaluating the association between carotid stiffening and incident stroke have been inconsistent. Therefore, we have conducted a systematic review and meta-analysis, showing that carotid stiffening is associated with incident stroke independently of cardiovascular risk factors and aortic stiffness. In addition, carotid stiffening improved stroke risk prediction beyond the Framingham stroke risk factors and aortic stiff...
Source: Pulse - April 14, 2016 Category: Cardiology Source Type: research

Dementia screening in elderly high-risk patients following heart failure decompensation may predict unfavorable long-term clinical outcomes.
CONCLUSIONS: In patients following decompensated HF, a history of stroke/TIA, PAD and impaired renal function independently influenced SDD. In this high-risk population, SDD was not related with patients' compliance but irrespective of the stroke/TIA history it was associated with the increased risk of HF rehospitalization. PMID: 32643895 [PubMed - as supplied by publisher]
Source: Minerva Cardioangiologica - July 10, 2020 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research